English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cisplatin is a chemotherapeutic agent, causes nephrotoxicity when it was administered for long periods. Our study conducted an investigation into the effect of ADMSCs in attenuation of cisplatin induced AKI. A total of 90 Sprague-Dawley rats (180–220 g) were apportioned to three groups: control group, cisplatin group, and ADMSCs + CP group. Ten rats were sacrificed on the days 3, 7 and 11, the kidney tissues and blood samples were obtained. Renal functions, oxidative stress parameters, molecular studies and histopathological studies were analyzed, as well as ADMSCs isolation and characterization was done. Cisplatin injection caused disturbance in kidney function through increasing serum creatinine, blood urea nitrogen and MDA, and decreasing GSH activity. The amelioration in renal function appeared at day 3 with the use of ADMSCs. Injection of cisplatin induced tubular apoptosis and inflammation by increasing Caspase-3 and NFKB, in addition to tubular degenerations evaluated by pathological score, in contrast, ADMSCs group showed a significantly lowered inflammation and apoptosis at days 3, 7, 11. This study concluded that ADMSCs have reno-protective effects that can be explained by three possible mechanisms of action, targeting oxidative stress, targeting apoptosis and reducing inflammation through which it could improve cisplatin toxicity.

Administration of Adipose derived mesenchymal stem cells promotes amelioration of renal function in cisplatin-induced acute kidney injury in rats.